Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | cerebrospinal fluid | Geigy Scientific Tables, 8th Rev edition. Edited by C. Lentner, West Cadwell, N.J.: Medical education Div., Ciba-Geigy Corp., Basel, Switzerland c1981-1992. | ||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[15196297] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
|||
NPO730 | Escherichia coli | Species | Enterobacteriaceae | Bacteria |
PMID[21988831] |
|||
NPO9249 | Jujubae fructus | NA | NA | NA | TCMSP* | |||
NPO28626 | Isodon rubescens | Species | Lamiaceae | Eukaryota | TM-MC* | |||
NPO5986 | Ziziphus jujuba | Species | Rhamnaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT5439 | Protein Family | Phosphodiesterase 3 | Homo sapiens | IC50 | = | 2400 | nM | 8568820 |
NPT5222 | Individual Protein | Phosphodiesterase 3B | Bos taurus | IC50 | = | 100 | nM | 8568820 |
NPT1028 | Individual Protein | Multidrug resistance-associated protein 4 | Homo sapiens | Activity | = | 16.2 | % | 11447229 |
NPT1027 | Individual Protein | Multidrug resistance-associated protein 5 | Homo sapiens | Activity | = | 37 | % | 12695538 |
NPT1028 | Individual Protein | Multidrug resistance-associated protein 4 | Homo sapiens | Activity | = | 46.5 | % | 12036927 |
NPT1028 | Individual Protein | Multidrug resistance-associated protein 4 | Homo sapiens | Activity | = | 48 | % | 12695538 |
NPT1736 | Individual Protein | ATP-binding cassette sub-family C member 11 | Homo sapiens | Activity | = | 73 | % | 15537867 |
NPT2773 | Individual Protein | Solute carrier family 22 member 7 | Homo sapiens | FC | = | 97 | 22190696 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC274384 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC89147 |
0.9774 | High Similarity | NPC251233 |
0.9774 | High Similarity | NPC211820 |
0.9773 | High Similarity | NPC186619 |
0.9701 | High Similarity | NPC177169 |
0.963 | High Similarity | NPC64705 |
0.963 | High Similarity | NPC232408 |
0.9627 | High Similarity | NPC318590 |
0.9556 | High Similarity | NPC317746 |
0.9398 | High Similarity | NPC30326 |
0.9394 | High Similarity | NPC61198 |
0.9318 | High Similarity | NPC262926 |
0.9098 | High Similarity | NPC319221 |
0.9023 | High Similarity | NPC324009 |
0.8851 | High Similarity | NPC14590 |
0.8686 | High Similarity | NPC320818 |
0.8378 | Intermediate Similarity | NPC302778 |
0.8378 | Intermediate Similarity | NPC212551 |
0.8367 | Intermediate Similarity | NPC185991 |
0.8367 | Intermediate Similarity | NPC85689 |
0.8367 | Intermediate Similarity | NPC211025 |
0.8311 | Intermediate Similarity | NPC321814 |
0.8267 | Intermediate Similarity | NPC224076 |
0.8258 | Intermediate Similarity | NPC327579 |
0.8255 | Intermediate Similarity | NPC130586 |
0.8255 | Intermediate Similarity | NPC164952 |
0.82 | Intermediate Similarity | NPC174802 |
0.8194 | Intermediate Similarity | NPC74306 |
0.8194 | Intermediate Similarity | NPC315642 |
0.8163 | Intermediate Similarity | NPC121222 |
0.8092 | Intermediate Similarity | NPC316618 |
0.8092 | Intermediate Similarity | NPC226245 |
0.8054 | Intermediate Similarity | NPC326694 |
0.8 | Intermediate Similarity | NPC161224 |
0.7962 | Intermediate Similarity | NPC261595 |
0.7959 | Intermediate Similarity | NPC156461 |
0.7959 | Intermediate Similarity | NPC21448 |
0.7959 | Intermediate Similarity | NPC107374 |
0.7911 | Intermediate Similarity | NPC321458 |
0.7911 | Intermediate Similarity | NPC324033 |
0.7905 | Intermediate Similarity | NPC189068 |
0.7905 | Intermediate Similarity | NPC164665 |
0.7852 | Intermediate Similarity | NPC309832 |
0.7852 | Intermediate Similarity | NPC219313 |
0.7852 | Intermediate Similarity | NPC269827 |
0.7834 | Intermediate Similarity | NPC323091 |
0.7823 | Intermediate Similarity | NPC229974 |
0.7712 | Intermediate Similarity | NPC321052 |
0.7687 | Intermediate Similarity | NPC209525 |
0.7687 | Intermediate Similarity | NPC161659 |
0.7628 | Intermediate Similarity | NPC54320 |
0.7628 | Intermediate Similarity | NPC311197 |
0.7628 | Intermediate Similarity | NPC313754 |
0.7597 | Intermediate Similarity | NPC472816 |
0.7584 | Intermediate Similarity | NPC314152 |
0.7568 | Intermediate Similarity | NPC317821 |
0.7564 | Intermediate Similarity | NPC52238 |
0.7561 | Intermediate Similarity | NPC326529 |
0.7516 | Intermediate Similarity | NPC239737 |
0.7515 | Intermediate Similarity | NPC319100 |
0.7515 | Intermediate Similarity | NPC189261 |
0.7515 | Intermediate Similarity | NPC324198 |
0.7468 | Intermediate Similarity | NPC150853 |
0.7423 | Intermediate Similarity | NPC326082 |
0.7372 | Intermediate Similarity | NPC207633 |
0.7267 | Intermediate Similarity | NPC129756 |
0.7179 | Intermediate Similarity | NPC136349 |
0.7044 | Intermediate Similarity | NPC328479 |
0.6974 | Remote Similarity | NPC33996 |
0.6933 | Remote Similarity | NPC195140 |
0.6857 | Remote Similarity | NPC313547 |
0.6768 | Remote Similarity | NPC93365 |
0.6744 | Remote Similarity | NPC313897 |
0.6726 | Remote Similarity | NPC324484 |
0.6706 | Remote Similarity | NPC290959 |
0.6691 | Remote Similarity | NPC59314 |
0.6686 | Remote Similarity | NPC325906 |
0.6594 | Remote Similarity | NPC119133 |
0.6573 | Remote Similarity | NPC63433 |
0.6556 | Remote Similarity | NPC313514 |
0.6549 | Remote Similarity | NPC41958 |
0.6471 | Remote Similarity | NPC293163 |
0.6389 | Remote Similarity | NPC24589 |
0.6379 | Remote Similarity | NPC222174 |
0.6374 | Remote Similarity | NPC282458 |
0.6374 | Remote Similarity | NPC78941 |
0.6331 | Remote Similarity | NPC10466 |
0.6257 | Remote Similarity | NPC321393 |
0.6207 | Remote Similarity | NPC33382 |
0.6204 | Remote Similarity | NPC320256 |
0.6171 | Remote Similarity | NPC125659 |
0.6171 | Remote Similarity | NPC168702 |
0.6165 | Remote Similarity | NPC107160 |
0.6154 | Remote Similarity | NPC21461 |
0.6149 | Remote Similarity | NPC240084 |
0.6082 | Remote Similarity | NPC157821 |
0.6062 | Remote Similarity | NPC276373 |
0.6031 | Remote Similarity | NPC5802 |
0.5991 | Remote Similarity | NPC158055 |
0.598 | Remote Similarity | NPC250178 |
0.5897 | Remote Similarity | NPC180462 |
0.5827 | Remote Similarity | NPC90240 |
0.5813 | Remote Similarity | NPC57279 |
0.5808 | Remote Similarity | NPC174020 |
0.5806 | Remote Similarity | NPC109322 |
0.5796 | Remote Similarity | NPC144223 |
0.5758 | Remote Similarity | NPC103388 |
0.5694 | Remote Similarity | NPC476561 |
0.569 | Remote Similarity | NPC60537 |
0.5687 | Remote Similarity | NPC287876 |
0.5671 | Remote Similarity | NPC470141 |
0.5669 | Remote Similarity | NPC248007 |
0.5643 | Remote Similarity | NPC280946 |
0.5643 | Remote Similarity | NPC226769 |
0.5643 | Remote Similarity | NPC6166 |
0.5625 | Remote Similarity | NPC14330 |
0.5603 | Remote Similarity | NPC120887 |
0.5602 | Remote Similarity | NPC210947 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC274384 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9394 | High Similarity | NPD252 | Clinical (unspecified phase) |
0.9286 | High Similarity | NPD3086 | Phase 3 |
0.9214 | High Similarity | NPD3085 | Phase 1 |
0.9034 | High Similarity | NPD4074 | Clinical (unspecified phase) |
0.903 | High Similarity | NPD194 | Clinical (unspecified phase) |
0.9015 | High Similarity | NPD9632 | Phase 3 |
0.8978 | High Similarity | NPD549 | Approved |
0.8367 | Intermediate Similarity | NPD283 | Approved |
0.8267 | Intermediate Similarity | NPD169 | Phase 2 |
0.8258 | Intermediate Similarity | NPD9607 | Approved |
0.8255 | Intermediate Similarity | NPD338 | Approved |
0.8255 | Intermediate Similarity | NPD242 | Approved |
0.82 | Intermediate Similarity | NPD339 | Approved |
0.8194 | Intermediate Similarity | NPD582 | Approved |
0.8182 | Intermediate Similarity | NPD9606 | Approved |
0.806 | Intermediate Similarity | NPD9409 | Discontinued |
0.8014 | Intermediate Similarity | NPD209 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD353 | Discontinued |
0.7962 | Intermediate Similarity | NPD247 | Clinical (unspecified phase) |
0.7959 | Intermediate Similarity | NPD250 | Approved |
0.7959 | Intermediate Similarity | NPD249 | Approved |
0.7955 | Intermediate Similarity | NPD9374 | Approved |
0.7943 | Intermediate Similarity | NPD545 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD307 | Approved |
0.7852 | Intermediate Similarity | NPD186 | Discovery |
0.7852 | Intermediate Similarity | NPD195 | Approved |
0.7829 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7817 | Intermediate Similarity | NPD547 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD4716 | Approved |
0.7803 | Intermediate Similarity | NPD9373 | Approved |
0.7758 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD1369 | Phase 2 |
0.7662 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD218 | Approved |
0.7628 | Intermediate Similarity | NPD220 | Clinical (unspecified phase) |
0.7628 | Intermediate Similarity | NPD219 | Phase 3 |
0.7628 | Intermediate Similarity | NPD217 | Approved |
0.7628 | Intermediate Similarity | NPD216 | Approved |
0.7628 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7628 | Intermediate Similarity | NPD2646 | Discontinued |
0.7584 | Intermediate Similarity | NPD185 | Approved |
0.7548 | Intermediate Similarity | NPD3107 | Discontinued |
0.7517 | Intermediate Similarity | NPD1430 | Approved |
0.7517 | Intermediate Similarity | NPD1431 | Approved |
0.7516 | Intermediate Similarity | NPD1732 | Phase 3 |
0.7515 | Intermediate Similarity | NPD4171 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD166 | Approved |
0.7451 | Intermediate Similarity | NPD775 | Approved |
0.745 | Intermediate Similarity | NPD193 | Suspended |
0.7436 | Intermediate Similarity | NPD214 | Approved |
0.7436 | Intermediate Similarity | NPD213 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD7988 | Suspended |
0.7365 | Intermediate Similarity | NPD1412 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD9375 | Discontinued |
0.7329 | Intermediate Similarity | NPD3083 | Approved |
0.7315 | Intermediate Similarity | NPD1808 | Phase 1 |
0.7181 | Intermediate Similarity | NPD1120 | Approved |
0.7181 | Intermediate Similarity | NPD1121 | Approved |
0.7179 | Intermediate Similarity | NPD548 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD6417 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7103 | Intermediate Similarity | NPD515 | Phase 1 |
0.7086 | Intermediate Similarity | NPD2632 | Approved |
0.7086 | Intermediate Similarity | NPD2630 | Approved |
0.7086 | Intermediate Similarity | NPD2631 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD4054 | Clinical (unspecified phase) |
0.7044 | Intermediate Similarity | NPD9605 | Phase 3 |
0.7041 | Intermediate Similarity | NPD5666 | Phase 2 |
0.6929 | Remote Similarity | NPD9584 | Phase 2 |
0.6901 | Remote Similarity | NPD9360 | Approved |
0.6875 | Remote Similarity | NPD7842 | Phase 2 |
0.6857 | Remote Similarity | NPD1692 | Approved |
0.6783 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.6768 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6733 | Remote Similarity | NPD248 | Discontinued |
0.6709 | Remote Similarity | NPD7158 | Phase 1 |
0.6691 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.6686 | Remote Similarity | NPD1776 | Approved |
0.6686 | Remote Similarity | NPD1777 | Approved |
0.6685 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD5682 | Phase 3 |
0.6685 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6667 | Remote Similarity | NPD9633 | Phase 3 |
0.6667 | Remote Similarity | NPD798 | Discontinued |
0.665 | Remote Similarity | NPD6381 | Phase 2 |
0.6647 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6611 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6594 | Remote Similarity | NPD9291 | Approved |
0.6577 | Remote Similarity | NPD9408 | Phase 3 |
0.6556 | Remote Similarity | NPD7138 | Phase 2 |
0.6547 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.645 | Remote Similarity | NPD6036 | Suspended |
0.6409 | Remote Similarity | NPD1063 | Phase 2 |
0.6383 | Remote Similarity | NPD9417 | Phase 3 |
0.6383 | Remote Similarity | NPD9416 | Phase 3 |
0.6259 | Remote Similarity | NPD1368 | Approved |
0.6258 | Remote Similarity | NPD282 | Approved |
0.625 | Remote Similarity | NPD3696 | Approved |
0.625 | Remote Similarity | NPD3695 | Approved |
0.6242 | Remote Similarity | NPD1119 | Phase 2 |
0.6205 | Remote Similarity | NPD3708 | Phase 2 |
0.6186 | Remote Similarity | NPD2876 | Phase 3 |
0.6186 | Remote Similarity | NPD2877 | Clinical (unspecified phase) |
0.6134 | Remote Similarity | NPD2965 | Clinical (unspecified phase) |
0.6122 | Remote Similarity | NPD2824 | Phase 2 |
0.6121 | Remote Similarity | NPD7531 | Clinical (unspecified phase) |
0.6119 | Remote Similarity | NPD5080 | Phase 2 |
0.6111 | Remote Similarity | NPD2253 | Discontinued |
0.6098 | Remote Similarity | NPD171 | Discontinued |
0.6077 | Remote Similarity | NPD1046 | Clinical (unspecified phase) |
0.6076 | Remote Similarity | NPD5340 | Clinical (unspecified phase) |
0.607 | Remote Similarity | NPD5079 | Phase 2 |
0.6065 | Remote Similarity | NPD1356 | Approved |
0.6065 | Remote Similarity | NPD1354 | Approved |
0.6065 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.6051 | Remote Similarity | NPD9650 | Phase 3 |
0.6042 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.6039 | Remote Similarity | NPD4812 | Phase 1 |
0.6036 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD9406 | Approved |
0.5991 | Remote Similarity | NPD6840 | Approved |
0.5963 | Remote Similarity | NPD7486 | Phase 1 |
0.5962 | Remote Similarity | NPD1127 | Approved |
0.5962 | Remote Similarity | NPD1128 | Approved |
0.5951 | Remote Similarity | NPD1118 | Discontinued |
0.5943 | Remote Similarity | NPD5768 | Phase 2 |
0.5939 | Remote Similarity | NPD4240 | Approved |
0.5935 | Remote Similarity | NPD281 | Approved |
0.5879 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5842 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.5842 | Remote Similarity | NPD2902 | Phase 2 |
0.5821 | Remote Similarity | NPD4495 | Phase 1 |
0.5805 | Remote Similarity | NPD2604 | Approved |
0.5805 | Remote Similarity | NPD3697 | Discontinued |
0.5802 | Remote Similarity | NPD535 | Approved |
0.5782 | Remote Similarity | NPD284 | Phase 1 |
0.5774 | Remote Similarity | NPD1730 | Discontinued |
0.5765 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.5762 | Remote Similarity | NPD3139 | Phase 3 |
0.5723 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5695 | Remote Similarity | NPD3138 | Phase 3 |
0.569 | Remote Similarity | NPD2180 | Approved |
0.5687 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5679 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5669 | Remote Similarity | NPD9084 | Phase 2 |
0.5642 | Remote Similarity | NPD527 | Clinical (unspecified phase) |
PubChem CID   | 24316 |
ChEMBL   | CHEMBL395336 |
ZINC   |
Molecular Weight:   | 345.05 |
ALogP:   | -1.542 |
MLogP:   | 1.13 |
XLogP:   | -2.712 |
# Rotatable Bonds:   | 4 |
Polar Surface Area:   | 181.32 |
# H-Bond Aceptor:   | 12 |
# H-Bond Donor:   | 5 |
# Rings:   | 4 |
# Heavy Atoms:   | 23 |